πŸ‡ΊπŸ‡Έ FDA
Patent

US 9175057

Immunogenic peptides and methods of use

granted A61KA61K2239/59A61K38/08

Quick answer

US patent 9175057 (Immunogenic peptides and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K2239/59, A61K38/08, A61K39/0011, A61K40/11